LINDSEY ACKERMAN: Open Payments
NPI 1689275026 · STERLING HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 12 payments from 9 companies in 2025. Trend: 2023 $2,054 · 2024 $84 · 2025 $371
Food & beverage: $278Education: $93
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $115 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| ABBVIE INC. | 2 | $64 |
| GlaxoSmithKline, LLC. | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Karyopharm Therapeutics Inc. | 1 | $19 |
| BeOne Medicines USA, Inc. | 1 | $19 |
| Blueprint Medicines Corporation | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: ERLEADA, DUPIXENT, IMBRUVICA, OJJAARA, EPKINLY, Nubeqa, LYNOZYFIC, RYBREVANT.
Industry payments across MI — which companies pay providers there.
